321 related articles for article (PubMed ID: 25729719)
21. Lymphoid aggregates in bone marrow mimic residual lymphoma after rituximab therapy for non-Hodgkin lymphoma.
Douglas VK; Gordon LI; Goolsby CL; White CA; Peterson LC
Am J Clin Pathol; 1999 Dec; 112(6):844-53. PubMed ID: 10587708
[TBL] [Abstract][Full Text] [Related]
22. Bone marrow staging in patients with non-Hodgkin's lymphoma: is flow cytometry a useful test?
Naughton MJ; Hess JL; Zutter MM; Bartlett NL
Cancer; 1998 Mar; 82(6):1154-9. PubMed ID: 9506363
[TBL] [Abstract][Full Text] [Related]
23. Bone marrow involvement in non-Hodgkin's lymphoma: increased diagnostic sensitivity by combination of immunocytology, cytomorphology and trephine histology.
Schwonzen M; Pohl C; Steinmetz T; Wickramanayake PD; Thiele J; Diehl V
Br J Haematol; 1992 Jul; 81(3):362-9. PubMed ID: 1382545
[TBL] [Abstract][Full Text] [Related]
24. Two-color flow cytometry with a CD19 gate for the evaluation of bone marrow involvement of B-cell lymphoma.
Kawano-Yamamoto C; Muroi K; Izumi T; Saito K; Ozawa K
Leuk Lymphoma; 2002 Nov; 43(11):2133-7. PubMed ID: 12533038
[TBL] [Abstract][Full Text] [Related]
25. [Clinicopathologic features and differential diagnosis of splenic B-cell marginal zone lymphoma involving bone marrow].
Sun Q; Zhang PH; Liu EB; Liu W; Li ZQ; Yang QY; Fang LH; Sun FJ; Chen HS; Qiu LG
Zhonghua Bing Li Xue Za Zhi; 2013 Apr; 42(4):234-8. PubMed ID: 23928529
[TBL] [Abstract][Full Text] [Related]
26. Bone marrow trephine biopsy involvement by lymphoma: pattern of involvement and concordance with flow cytometry, in 10 years from a single institution.
Cabezas-Quintario MA; Gomez P; Yuste-Del Pozo V; Valencia-Mesa AL; Sosa G; Ricard P; Hijas-Gómez AI; Pinedo F; Arguelles M
Clin Transl Oncol; 2016 May; 18(5):537-40. PubMed ID: 26311078
[TBL] [Abstract][Full Text] [Related]
27. Leukemic phase of mantle cell lymphoma presenting as anemia: diagnosis by combining flow cytometry and cytomorphology.
Brink DS; Grosso LE; Dunphy CH
Arch Pathol Lab Med; 1998 Nov; 122(11):1018-22. PubMed ID: 9822132
[TBL] [Abstract][Full Text] [Related]
28. [Correlation of results of flow cytometry and morphologic findings in the diagnosis of malignant B-cell lymphoma].
Mand'áková P; Campr V; Kodet R
Cas Lek Cesk; 2003; 142(11):651-5. PubMed ID: 14689823
[TBL] [Abstract][Full Text] [Related]
29. Critical analysis and diagnostic usefulness of limited immunophenotyping of B-cell non-Hodgkin lymphomas by flow cytometry.
Kaleem Z; White G; Vollmer RT
Am J Clin Pathol; 2001 Jan; 115(1):136-42. PubMed ID: 11190799
[TBL] [Abstract][Full Text] [Related]
30. Combining morphology and flow cytometric immunophenotyping to evaluate bone marrow specimens for B-cell malignant neoplasms.
Dunphy CH
Am J Clin Pathol; 1998 May; 109(5):625-30. PubMed ID: 9576583
[TBL] [Abstract][Full Text] [Related]
31. Immunophenotypic analysis of peripheral blood and bone marrow in the staging of B-cell malignant lymphoma.
Hanson CA; Kurtin PJ; Katzmann JA; Hoyer JD; Li CY; Hodnefield JM; Meyers CH; Habermann TM; Witzig TE
Blood; 1999 Dec; 94(11):3889-96. PubMed ID: 10572105
[TBL] [Abstract][Full Text] [Related]
32. Flow cytometric immunophenotyping is of great value to diagnosis of natural killer cell neoplasms involving bone marrow and peripheral blood.
Jiang NG; Jin YM; Niu Q; Zeng TT; Su J; Zhu HL
Ann Hematol; 2013 Jan; 92(1):89-96. PubMed ID: 22992980
[TBL] [Abstract][Full Text] [Related]
33. CD10 expression in follicular lymphoma and large cell lymphoma is different from that of reactive lymph node follicles.
Almasri NM; Iturraspe JA; Braylan RC
Arch Pathol Lab Med; 1998 Jun; 122(6):539-44. PubMed ID: 9625422
[TBL] [Abstract][Full Text] [Related]
34. Morphologic, flow cytometric and cytogenetic evaluation of bone marrow involvement in B-cell lymphoma.
Gomyo H; Shimoyama M; Minagawa K; Yakushijin K; Urahama N; Okamura A; Yamamoto K; Ito M; Chihara K; Hayashi Y; Matsui T
Haematologica; 2003 Dec; 88(12):1358-65. PubMed ID: 14687988
[TBL] [Abstract][Full Text] [Related]
35. Minimal residual disease detection in mantle cell lymphoma: methods and significance of four-color flow cytometry compared to consensus IGH-polymerase chain reaction at initial staging and for follow-up examinations.
Böttcher S; Ritgen M; Buske S; Gesk S; Klapper W; Hoster E; Hiddemann W; Unterhalt M; Dreyling M; Siebert R; Kneba M; Pott C;
Haematologica; 2008 Apr; 93(4):551-9. PubMed ID: 18379010
[TBL] [Abstract][Full Text] [Related]
36. State of the Art Symposium: flow cytometry in the diagnosis of lymphoproliferative disorders by fine-needle aspiration.
Jorgensen JL
Cancer; 2005 Dec; 105(6):443-51. PubMed ID: 16155944
[No Abstract] [Full Text] [Related]
37. T-cell lymphoid aggregates in bone marrow after rituximab therapy for B-cell follicular lymphoma: a marker of therapeutic efficacy?
Raynaud P; Caulet-Maugendre S; Foussard C; Salles G; Moreau A; Rossi JF; Patey M; Rousselet MC; Bene MC; Damotte D; Cornillet Lefebvre P; Martin A; Costes V;
Hum Pathol; 2008 Feb; 39(2):194-200. PubMed ID: 17949786
[TBL] [Abstract][Full Text] [Related]
38. Immunophenotypic variability of B-cell non-Hodgkin lymphoma: a retrospective study of cases analyzed by flow cytometry.
Echeverri C; Fisher S; King D; Craig FE
Am J Clin Pathol; 2002 Apr; 117(4):615-20. PubMed ID: 11939737
[TBL] [Abstract][Full Text] [Related]
39. [Identification of splenic marginal zone lymphoma from B lymphoproliferative disorders by flow cytometry].
Hu Y; Chen Y; Wang LH; Chen X; Fang F; Liu SQ; Wu XQ; Zhu P
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Apr; 22(2):349-56. PubMed ID: 24763004
[TBL] [Abstract][Full Text] [Related]
40. Fine-needle aspiration biopsy and flow cytometry immunophenotyping of lymphoid and myeloproliferative disorders of the spleen.
Zeppa P; Picardi M; Marino G; Troncone G; Fulciniti F; Vetrani A; Rotoli B; Palombini L
Cancer; 2003 Apr; 99(2):118-27. PubMed ID: 12704692
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
